Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.004 AUD | +14.29% | -20.00% | +14.29% |
03-25 | Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial | MT |
03-14 | Avecho to Push Forward with Phase III Trial of Anti-Insomnia Drug | MT |
1st Jan change | Capi. | |
---|---|---|
+14.29% | 8.23M | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- AVE Stock
- News Avecho Biotechnology Limited
- Avecho Biotechnology Limited Reports Earnings Results for the Half Year Ended June 30, 2021